Prosight Management, LP Shattuck Labs, Inc. Transaction History
Prosight Management, LP
- $281 Million
- Q1 2025
A detailed history of Prosight Management, LP transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 6,638,935 shares of STTK stock, worth $7.57 Million. This represents 2.25% of its overall portfolio holdings.
Number of Shares
6,638,935
Previous 6,638,935
-0.0%
Holding current value
$7.57 Million
Previous $8.03 Million
21.5%
% of portfolio
2.25%
Previous 2.39%
Shares
14 transactions
Others Institutions Holding STTK
# of Institutions
77Shares Held
31MCall Options Held
0Put Options Held
0-
Redmile Group, LLC San Francisco, CA5.54MShares$6.32 Million0.55% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$5.33 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$2.82 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.4MShares$2.74 Million0.0% of portfolio
-
Clark Estates Inc New York, NY1.48MShares$1.68 Million0.4% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $48.3M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...